211 related articles for article (PubMed ID: 34320447)
1. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
Guerra E; Trerotola M; Relli V; Lattanzio R; Tripaldi R; Vacca G; Ceci M; Boujnah K; Garbo V; Moschella A; Zappacosta R; Simeone P; de Lange R; Weidle UH; Rotelli MT; Picciariello A; Depalo R; Querzoli P; Pedriali M; Bianchini E; Angelucci D; Pizzicannella G; Di Loreto C; Piantelli M; Antolini L; Sun XF; Altomare DF; Alberti S
Neoplasia; 2021 Sep; 23(9):898-911. PubMed ID: 34320447
[TBL] [Abstract][Full Text] [Related]
2. Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis.
Trerotola M; Guerra E; Ali Z; Aloisi AL; Ceci M; Simeone P; Acciarito A; Zanna P; Vacca G; D'Amore A; Boujnah K; Garbo V; Moschella A; Lattanzio R; Alberti S
Neoplasia; 2021 Apr; 23(4):415-428. PubMed ID: 33839455
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
Park GB; Kim D
Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
[TBL] [Abstract][Full Text] [Related]
4. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
Park GB; Kim D
Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
[TBL] [Abstract][Full Text] [Related]
5. Trophoblast cell surface antigen-2 phosphorylation triggered by binding of galectin-3 drives metastasis through down-regulation of E-cadherin.
Iwamoto S; Mori Y; Yamashita T; Ojima K; Akita K; Togano S; Kushiyama S; Yashiro M; Yatera Y; Yamaguchi T; Komiyama A; Sago Y; Itano N; Nakada H
J Biol Chem; 2023 Aug; 299(8):104971. PubMed ID: 37380081
[TBL] [Abstract][Full Text] [Related]
6. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.
Mueller AC; Piper M; Goodspeed A; Bhuvane S; Williams JS; Bhatia S; Phan AV; Van Court B; Zolman KL; Peña B; Oweida AJ; Zakem S; Meguid C; Knitz MW; Darragh L; Bickett TE; Gadwa J; Mestroni L; Taylor MRG; Jordan KR; Dempsey P; Lucia MS; McCarter MD; Del Chiaro M; Messersmith WA; Schulick RD; Goodman KA; Gough MJ; Greene CS; Costello JC; Neto AG; Lagares D; Hansen KC; Van Bokhoven A; Karam SD
Cancer Res; 2021 Jun; 81(12):3255-3269. PubMed ID: 33526513
[TBL] [Abstract][Full Text] [Related]
7. Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin.
Kouam PN; Rezniczek GA; Adamietz IA; Bühler H
BMC Cancer; 2019 Oct; 19(1):958. PubMed ID: 31619190
[TBL] [Abstract][Full Text] [Related]
8. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
Gavert N; Sheffer M; Raveh S; Spaderna S; Shtutman M; Brabletz T; Barany F; Paty P; Notterman D; Domany E; Ben-Ze'ev A
Cancer Res; 2007 Aug; 67(16):7703-12. PubMed ID: 17699774
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.
Vezzoli E; Caron I; Talpo F; Besusso D; Conforti P; Battaglia E; Sogne E; Falqui A; Petricca L; Verani M; Martufi P; Caricasole A; Bresciani A; Cecchetti O; Rivetti di Val Cervo P; Sancini G; Riess O; Nguyen H; Seipold L; Saftig P; Biella G; Cattaneo E; Zuccato C
J Clin Invest; 2019 May; 129(6):2390-2403. PubMed ID: 31063986
[TBL] [Abstract][Full Text] [Related]
11. Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition.
Remšík J; Binó L; Kahounová Z; Kharaishvili G; Šimecková Š; Fedr R; Kucírková T; Lenárt S; Muresan XM; Slabáková E; Knopfová L; Bouchal J; Král M; Beneš P; Soucek K
Carcinogenesis; 2018 Dec; 39(11):1411-1418. PubMed ID: 30010814
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
13. ADAM10-Interacting Tetraspanins Tspan5 and Tspan17 Regulate VE-Cadherin Expression and Promote T Lymphocyte Transmigration.
Reyat JS; Chimen M; Noy PJ; Szyroka J; Rainger GE; Tomlinson MG
J Immunol; 2017 Jul; 199(2):666-676. PubMed ID: 28600292
[TBL] [Abstract][Full Text] [Related]
14. TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity.
Lee Y; Ko D; Yoon J; Lee Y; Kim S
J Exp Clin Cancer Res; 2021 Mar; 40(1):58. PubMed ID: 33641663
[TBL] [Abstract][Full Text] [Related]
15. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
[TBL] [Abstract][Full Text] [Related]
16. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
17. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
[TBL] [Abstract][Full Text] [Related]
18. PAX2 may induce ADAM10 expression in renal tubular epithelial cells and contribute to epithelial-to-mesenchymal transition.
Hou L; Du Y; Zhao C; Wu Y
Int Urol Nephrol; 2018 Sep; 50(9):1729-1741. PubMed ID: 30117015
[TBL] [Abstract][Full Text] [Related]
19. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
[TBL] [Abstract][Full Text] [Related]
20. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.
Maretzky T; Reiss K; Ludwig A; Buchholz J; Scholz F; Proksch E; de Strooper B; Hartmann D; Saftig P
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9182-7. PubMed ID: 15958533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
